Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panaccione

Showing results (461-470 of 652) with videos related to

Pageof 66
Sort By:
Current Medical Research and Opinion|July 10, 2025
Impact of moderate-to-severe ulcerative colitis and Crohn's disease on sexual activity: United States and European patient perspectives from the communicating needs and features of IBD experiences (CONFIDE) surveyMarla C Dubinsky, Alison Potts Bleakman, Stefan Schreiber, et al.
Inflammatory Bowel Diseases|November 1, 2011
Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus reportBrian G Feagan, Marc Lémann, Ragnar Befrits, et al.
The Review of Scientific Instruments|April 4, 2023
Dual pulsed laser deposition system for the growth of complex materials and heterostructuresP Orgiani, S K Chaluvadi, S Punathum Chalil, et al.
Journal of Crohn'S & Colitis|January 21, 2012
Physician perspectives on unresolved issues in the use of conventional therapy in Crohn's disease: results from an international survey and discussion programmeMarc Ferrante, Konstantinos Karmiris, Evan Newnham, et al.
The Review of Scientific Instruments|September 3, 2020
An integrated ultra-high vacuum apparatus for growth and in situ characterization of complex materialsG Vinai, F Motti, A Yu Petrov, et al.
Journal of Crohn'S & Colitis|November 19, 2025
Serum protein profiles differ with adalimumab and ustekinumab treatment in moderately to severely active Crohn's diseaseSwati Venkat, Martha Zeeman, Amy Hart, et al.
Journal of Crohn'S & Colitis|February 14, 2012
Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensusWalter Reinisch, Gert Van Assche, Ragnar Befrits, et al.
Lancet (London, England)|October 21, 2017
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studiesSiew C Ng, Hai Yun Shi, Nima Hamidi, et al.
Physical Review Letters|June 4, 2008
Nature of the band gap of In2O3 revealed by first-principles calculations and x-ray spectroscopyAron Walsh, Juarez L F Da Silva, Su-Huai Wei, et al.
The Lancet. Gastroenterology & Hepatology|October 14, 2022
Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trialWilliam J Sandborn, Julian Panés, Silvio Danese, et al.
Pageof 66

Showing results (461-470 of 652) with videos related to

Sort By:
Pageof 66
Current Medical Research and Opinion|July 10, 2025
Impact of moderate-to-severe ulcerative colitis and Crohn's disease on sexual activity: United States and European patient perspectives from the communicating needs and features of IBD experiences (CONFIDE) surveyMarla C Dubinsky, Alison Potts Bleakman, Stefan Schreiber, et al.
Inflammatory Bowel Diseases|November 1, 2011
Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus reportBrian G Feagan, Marc Lémann, Ragnar Befrits, et al.
The Review of Scientific Instruments|April 4, 2023
Dual pulsed laser deposition system for the growth of complex materials and heterostructuresP Orgiani, S K Chaluvadi, S Punathum Chalil, et al.
Journal of Crohn'S & Colitis|January 21, 2012
Physician perspectives on unresolved issues in the use of conventional therapy in Crohn's disease: results from an international survey and discussion programmeMarc Ferrante, Konstantinos Karmiris, Evan Newnham, et al.
The Review of Scientific Instruments|September 3, 2020
An integrated ultra-high vacuum apparatus for growth and in situ characterization of complex materialsG Vinai, F Motti, A Yu Petrov, et al.
Journal of Crohn'S & Colitis|November 19, 2025
Serum protein profiles differ with adalimumab and ustekinumab treatment in moderately to severely active Crohn's diseaseSwati Venkat, Martha Zeeman, Amy Hart, et al.
Journal of Crohn'S & Colitis|February 14, 2012
Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensusWalter Reinisch, Gert Van Assche, Ragnar Befrits, et al.
Lancet (London, England)|October 21, 2017
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studiesSiew C Ng, Hai Yun Shi, Nima Hamidi, et al.
Physical Review Letters|June 4, 2008
Nature of the band gap of In2O3 revealed by first-principles calculations and x-ray spectroscopyAron Walsh, Juarez L F Da Silva, Su-Huai Wei, et al.
The Lancet. Gastroenterology & Hepatology|October 14, 2022
Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trialWilliam J Sandborn, Julian Panés, Silvio Danese, et al.
Pageof 66